2022 ICD-10-CM Code D05.90
Unspecified type of carcinoma in situ of unspecified breast
Code Classification
D05.90 is a billable diagnosis code used to specify a medical diagnosis of unspecified type of carcinoma in situ of unspecified breast. The code D05.90 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D05.90 might also be used to specify conditions or terms like carcinoma in situ of areola of female breast, carcinoma in situ of areola of male breast, carcinoma in situ of axillary tail of female breast, carcinoma in situ of breast, carcinoma in situ of central portion of female breast , carcinoma in situ of ectopic female breast tissue, etc.
Unspecified diagnosis codes like D05.90 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Carcinoma in situ of areola of female breast
- Carcinoma in situ of areola of male breast
- Carcinoma in situ of axillary tail of female breast
- Carcinoma in situ of breast
- Carcinoma in situ of central portion of female breast
- Carcinoma in situ of ectopic female breast tissue
- Carcinoma in situ of ectopic male breast tissue
- Carcinoma in situ of female breast
- Carcinoma in situ of lower inner quadrant of female breast
- Carcinoma in situ of lower outer quadrant of female breast
- Carcinoma in situ of male breast
- Carcinoma in situ of nipple of female breast
- Carcinoma in situ of nipple of male breast
- Carcinoma in situ of upper inner quadrant of female breast
- Carcinoma in situ of upper outer quadrant of female breast
- Neoplasm of areola of female breast
- Neoplasm of areola of male breast
- Neoplasm of ectopic female breast tissue
- Neoplasm of ectopic male breast tissue
- Neoplasm of lower inner quadrant of female breast
- Neoplasm of lower outer quadrant of female breast
- Neoplasm of nipple of female breast
- Neoplasm of nipple of male breast
- Neoplasm of upper inner quadrant of female breast
- Neoplasm of upper outer quadrant of female breast
- Papillary carcinoma in situ of breast
- Primary intracystic papillary carcinoma of breast
- pTis: Carcinoma in situ
- pTis: Paget disease without invasive carcinoma
- Solid papillary carcinoma in situ of breast
- Tis: Carcinoma in situ, breast: Intraductal carcinoma, lobular carcinoma in situ, or Paget's disease of the nipple with no tumor
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code D05.90 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
MS-DRG | MS-DRG Title | MCD | Relative Weight |
---|---|---|---|
582 | MASTECTOMY FOR MALIGNANCY WITH CC/MCC | 09 | 1.6416 |
583 | MASTECTOMY FOR MALIGNANCY WITHOUT CC/MCC | 09 | 1.5416 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert D05.90 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code D05.90 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 233.0 - Ca in situ breast (Approximate Flag)
Information for Patients
Breast Cancer
What is breast cancer?
Breast cancer is a cancer that starts in breast tissue. It happens when cells in the breast change and grow out of control. The cells usually form a tumor.
Sometimes the cancer does not spread any further. This is called "in situ." If the cancer spreads outside the breast, the cancer is called "invasive." It may just spread to nearby tissues and lymph nodes. Or the cancer may metastasize (spread to other parts of the body) through the lymph system or the blood.
Breast cancer is the second most common type of cancer in women in the United States. Rarely, it can also affect men.
What are the types of breast cancer?
There are different types of breast cancer. The types are based on which breast cells turn into cancer. The types include
- Ductal carcinoma, which begins in the cells of the ducts. This is the most common type.
- Lobular carcinoma, which begins in the lobules. It is more often found in both breasts than other types of breast cancer.
- Inflammatory breast cancer, in which cancer cells block lymph vessels in the skin of the breast. The breast becomes warm, red, and swollen. This is a rare type.
- Paget's disease of the breast, which is a cancer involving the skin of the nipple. It usually also affects the darker skin around the nipple. It is also rare.
What causes breast cancer?
Breast cancer happens when there are changes in the genetic material (DNA). Often, the exact cause of these genetic changes is unknown.
But sometimes these genetic changes are inherited, meaning that you are born with them. Breast cancer that is caused by inherited genetic changes is called hereditary breast cancer.
There are also certain genetic changes that can raise your risk of breast cancer, including changes called BRCA1 and BRCA2. These two changes also raise your risk of ovarian and other cancers.
Besides genetics, your lifestyle and the environment can affect your risk of breast cancer.
Who is at risk for breast cancer?
The factors which raise your risk of breast cancer include
- Older age
- History of breast cancer or benign (noncancer) breast disease
- Inherited risk of breast cancer, including having BRCA1 and BRCA2 gene changes
- Dense breast tissue
- A reproductive history that leads to more exposure to the estrogen hormone, including
- Menstruating at an early age
- Being at an older age when you first gave birth or never having given birth
- Starting menopause at a later age
- Taking hormone therapy for symptoms of menopause
- Radiation therapy to the breast or chest
- Obesity
- Drinking alcohol
What are the signs and symptoms of breast cancer?
The signs and symptoms of breast cancer include
- A new lump or thickening in or near the breast or in the armpit
- A change in the size or shape of the breast
- A dimple or puckering in the skin of the breast. It may look like the skin of an orange.
- A nipple turned inward into the breast
- Nipple discharge other than breast milk. The discharge might happen suddenly, be bloody, or happen in only one breast.
- Scaly, red, or swollen skin in the nipple area or the breast
- Pain in any area of the breast
How is breast cancer diagnosed?
Your health care provider may use many tools to diagnose breast cancer and figure out which type you have:
- A physical exam, including a clinical breast exam (CBE). This involves checking for any lumps or anything else that seems unusual with the breasts and armpits.
- A medical history
- Imaging tests, such as a mammogram, an ultrasound, or an MRI
- Breast biopsy
- Blood chemistry tests, which measure different substances in the blood, including electrolytes, fats, proteins, glucose (sugar), and enzymes. Some of the specific blood chemistry tests include a basic metabolic panel (BMP), a comprehensive metabolic panel (CMP), and an electrolyte panel.
If these tests show that you have breast cancer, you will have tests which study the cancer cells. These tests help your provider decide which treatment would be best for you. The tests may include
- Genetic tests for genetic changes such as BRCA and TP53
- HER2 test. HER2 is a protein involved with cell growth. It is on the outside of all breast cells. If your breast cancer cells have more HER2 than normal, they can grow more quickly and spread to other parts of the body.
- An estrogen and progesterone receptor test. This test measures the amount of estrogen and progesterone (hormones) receptors in cancer tissue. If there are more receptors than normal, the cancer is called estrogen and/or progesterone receptor positive. This type of breast cancer may grow more quickly.
Another step is staging the cancer. Staging involves doing tests to find out whether the cancer has spread within the breast or to other parts of the body. The tests may include other diagnostic imaging tests and a sentinel lymph node biopsy. This biopsy is done to see whether the cancer has spread to the lymph nodes.
What are the treatments for breast cancer?
Treatments for breast cancer include
- Surgery such as
- A mastectomy, which removes the whole breast
- A lumpectomy to remove the cancer and some normal tissue around it, but not the breast itself
- Radiation therapy
- Chemotherapy
- Hormone therapy, which blocks cancer cells from getting the hormones they need to grow
- Targeted therapy, which uses drugs or other substances that attack specific cancer cells with less harm to normal cells
- Immunotherapy
Can breast cancer be prevented?
You may be able to help prevent breast cancer by making healthy lifestyle changes such as
- Staying at a healthy weight
- Limiting alcohol use
- Getting enough exercisee
- Limiting your exposure to estrogen by
- Breastfeeding your babies if you can
- Limiting hormone therapy
If you are at high risk, your health care provider may suggest that you take certain medicines to lower the risk. Some women at very high risk may decide to get a mastectomy (of their healthy breasts) to prevent breast cancer.
It's also important to get regular mammograms. They may be able to identify breast cancer in the early stages, when it is easier to treat.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Breast cancer
Breast cancer is a disease in which certain cells in the breast become abnormal and multiply uncontrollably to form a tumor. Although breast cancer is much more common in women, this form of cancer can also develop in men. In both women and men, the most common form of breast cancer begins in cells lining the milk ducts (ductal cancer). In women, cancer can also develop in the glands that produce milk (lobular cancer). Most men have little or no lobular tissue, so lobular cancer in men is very rare.
In its early stages, breast cancer usually does not cause pain and may exhibit no noticeable symptoms. As the cancer progresses, signs and symptoms can include a lump or thickening in or near the breast; a change in the size or shape of the breast; nipple discharge, tenderness, or retraction (turning inward); and skin irritation, dimpling, redness, or scaliness. However, these changes can occur as part of many different conditions. Having one or more of these symptoms does not mean that a person definitely has breast cancer.
In some cases, cancerous cells can invade surrounding breast tissue. In these cases, the condition is known as invasive breast cancer. Sometimes, tumors spread to other parts of the body. If breast cancer spreads, cancerous cells most often appear in the bones, liver, lungs, or brain. Tumors that begin at one site and then spread to other areas of the body are called metastatic cancers.
A small percentage of all breast cancers cluster in families. These cancers are described as hereditary and are associated with inherited gene mutations. Hereditary breast cancers tend to develop earlier in life than noninherited (sporadic) cases, and new (primary) tumors are more likely to develop in both breasts.
[Learn More in MedlinePlus]
Breast Cancer Summary Learn about breast cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]
Related Codes
ICD Code | Description | Valid for Submission |
---|---|---|
D05 | Carcinoma in situ of breast | NON-BILLABLE CODE |
D05.0 | Lobular carcinoma in situ of breast | NON-BILLABLE CODE |
D05.00 | Lobular carcinoma in situ of unspecified breast | BILLABLE CODE |
D05.01 | Lobular carcinoma in situ of right breast | BILLABLE CODE |
D05.02 | Lobular carcinoma in situ of left breast | BILLABLE CODE |
D05.1 | Intraductal carcinoma in situ of breast | NON-BILLABLE CODE |
D05.10 | Intraductal carcinoma in situ of unspecified breast | BILLABLE CODE |
D05.11 | Intraductal carcinoma in situ of right breast | BILLABLE CODE |
D05.12 | Intraductal carcinoma in situ of left breast | BILLABLE CODE |
D05.8 | Other specified type of carcinoma in situ of breast | NON-BILLABLE CODE |
D05.80 | Other specified type of carcinoma in situ of unspecified breast | BILLABLE CODE |
D05.81 | Other specified type of carcinoma in situ of right breast | BILLABLE CODE |
D05.82 | Other specified type of carcinoma in situ of left breast | BILLABLE CODE |
D05.9 | Unspecified type of carcinoma in situ of breast | NON-BILLABLE CODE |
D05.91 | Unspecified type of carcinoma in situ of right breast | BILLABLE CODE |
D05.92 | Unspecified type of carcinoma in situ of left breast | BILLABLE CODE |
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)